Bio-Rad produces informational webinars throughout the year on a wide range of research topics and technologies. Join Bio-Rad experts and renowned researchers from around the world to learn about current research issues and advances and see how Bio‑Rad products and innovations are being used in cutting-edge discoveries.
2-D Electrophoresis Tips & Tricks — Part I
In the first half of this two-part presentation, Dr. Anton Posch, an expert in 1- and 2-D electrophoresis, provides tips and tricks for the 2DE workflow, covering sample preparation, protein extraction and solubilization, reduction and alkylation of protein side chains, and IEF. The webinar highlights critical success factors and is aimed at both novices and experts wanting to sharpen their skills and keep up on new advances in the field.
2-D Electrophoresis Tips & Tricks — Part II
In the second part of this presentation, Dr. Posch details IEF separation, use of immobilized pH gradient (IPG) strips, running second-dimension PAGE, spot detection, gel matching, and data analysis. The Q&A elaborates on sample preparation, storage, and running conditions.
Using Droplet Digital™ PCR to Study Stem Cell Genomes at Stanford University
In this webinar, Prof. Alexander Urban of the Stanford School of Medicine describes how his lab used the QX200™ Droplet Digital™ PCR System to investigate copy number variation (CNV) in induced pluripotent stem cells (iPSCs) that were being used to study the genetics of autism.
Can Droplet Digital™ PCR Detect 22q11.2 Deletion Syndrome?
This presentation by Vicki Hwang details how UC Davis researchers used Droplet Digital PCR (ddPCR™) technology to determine copy number variation (CNV) and characterize the deletion endpoints of the region of chromosome 22 that is deleted in 22q11 deletion syndrome.
Digital Quantitation of Potential Therapeutic Target RNAs
In this webinar, Dr. David Dodd describes how he and Prof. David Corey and colleagues at UT Southwestern Medical Center have used Droplet Digital™ PCR (ddPCR™) in their research into low-abundance targets with therapeutic potential for cancer and Huntington’s disease.